Differential Gene Expression in the Penile Cavernosum of Streptozotocin-Induced Diabetic Rats
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Men with diabetes mellitus (DM) often present with severe erectile dysfunction (ED). This ED is less responsive to current pharmacological therapies. If we know the upregulated or downregulated genes of diabetic ED, we can inhibit or enhance the expression of such genes through RNA or gene overexpression. Methods: To investigate gene changes associated with ED in type 1 DM, we examined the alterations of gene expression in the cavernosum of streptozotocin-induced diabetic rats. Specifically, we considered 11,636 genes (9,623 upregulated and 2,013 downregulated) to be differentially expressed in the diabetic rat cavernosum group (n=4) compared to the control group (n=4). The analysis of differentially expressed genes using the gene ontology (GO) classification indicated that the following were enriched: downregulated genes such as cell cycle, extracellular matrix, glycosylphosphatidylinositol-anchor biosynthesis and upregulated genes such as calcium signaling, neurotrophin signaling, apoptosis, arginine and proline metabolism, gap junction, transforming growth factor-β signaling, tight junction, vascular smooth muscle contraction, and vascular endothelial growth factor (VEGF) signaling. We examined a more than 2-fold upregulated or downregulated change in expression, using real time polymerase chain reaction. Analysis of differentially expressed genes, using the GO classification, indicated the enrichment Results: Of the 41,105 genes initially considered, statistical filtering of the array analysis showed 9,623 upregulated genes and 2,013 downregulated genes with at least 2-fold changes in expression (P<0.05). With Bonferroni correction, SLC2A9 (solute carrier family 2 member 9), LRRC20 (leucine rick repeat containing 20), PLK1 (polo like kinase 1), and AATK (apoptosis-associated tyrosine kinase) were all 2-fold changed genes. Conclusions: This study broadens the scope of candidate genes that may be relevant to the pathophysiology of diabetic ED. In particular, their enhancement or inhibition could represent a novel treatment for diabetic ED.
Abstract
Purpose: Men with diabetes mellitus (DM) often present with severe erectile dysfunction (ED). This ED is less responsive to current pharmacological therapies. If we know the upregulated or downregulated genes of diabetic ED, we can inhibit or enhance the expression of such genes through RNA or gene overexpression. Methods: To investigate gene changes associated with ED in type 1 DM, we examined the alterations of gene expression in the cavernosum of streptozotocin-induced diabetic rats. Specifically, we considered 11,636 genes (9,623 upregulated and 2,013 downregulated) to be differentially expressed in the diabetic rat cavernosum group (n=4) compared to the control group (n=4). The analysis of differentially expressed genes using the gene ontology (GO) classification indicated that the following were enriched: downregulated genes such as cell cycle, extracellular matrix, glycosylphosphatidylinositol-anchor biosynthesis and upregulated genes such as calcium signaling, neurotrophin signaling, apoptosis, arginine and proline metabolism, gap junction, transforming growth factor-β signaling, tight junction, vascular smooth muscle contraction, and vascular endothelial growth factor (VEGF) signaling. We examined a more than 2-fold upregulated or downregulated change in expression, using real time polymerase chain reaction. Analysis of differentially expressed genes, using the GO classification, indicated the enrichment Results: Of the 41,105 genes initially considered, statistical filtering of the array analysis showed 9,623 upregulated genes and 2,013 downregulated genes with at least 2-fold changes in expression (P<0.05). With Bonferroni correction, SLC2A9 (solute carrier family 2 member 9), LRRC20 (leucine rick repeat containing 20), PLK1 (polo like kinase 1), and AATK (apoptosis-associated tyrosine kinase) were all 2-fold changed genes. Conclusions: This study broadens the scope of candidate genes that may be relevant to the pathophysiology of diabetic ED. In particular, their enhancement or inhibition could represent a novel treatment for diabetic ED.
참고문헌 (32)
- Engelgau MM, "Addressing the burden of diabetes in the 21st century : better care and primary prevention", J Am Soc Nephrol, 14(7 Suppl 2), pp.S88~S91 (2003)
- Zimmet P, "Global and societal implications of the diabetes epidemic", Nature, 414, pp.782~787 (2001)
- Permutt MA, "Genetic epidemiology of diabetes", J Clin Invest, 115, pp.1431~1439 (2005)
- Wild S, "Global prevalence of diabetes : estimates for the year 2000 and projections for 2030", Diabetes Care, 27, pp.1047~1053 (2004)
- Hakim LS, "Diabetic sexual dysfunction", Endocrinol Metab Clin North Am, 25, pp.379~400 (1996)
- Feldman HA, "Impotence and its medical and psychosocial correlates : results of the Massachusetts Male Aging Study", J Urol, 151, pp.54~61 (1994)
- Rosen RC, "The multinational Men’s Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population", Curr Med Res Opin, 20, pp.607~617 (2004)
- Basu A, "New treatment options for erectile dysfunction in patients with diabetes mellitus", Drugs, 64, pp.2667~2688 (2004)
- Brown JS, "Urologic complications of diabetes", Diabetes Care, 28, pp.177~185 (2005)
- Guay AT, "Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors", J Androl, 22, pp.793~797 (2001)
- Penson DF, "Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database", Diabetes Care, 26, pp.1093~1099 (2003)
- Christ GJ, "Effects of streptozotocin-induced diabetes on bladder and erectile(dys)function in the same rat in vivo", BJU Int, 97, pp.1076~1082 (2006)
- Furman BL, "Streptozotocin-induced diabetic models in mice and rats", Curr Protoc Pharmacol, 70(5), pp.47.1~47.20 (2015)
- Rehman J, "Intracavernous pressure responses to physical and electrical stimulation of the cavernous nerve in rats", Urology, 51, pp.640~644 (1998)
- Kim JH, "Improvement of damaged cavernosa followed by neuron-like differentiation at injured cavernous nerve after transplantation of stem cells seeded on the PLA nanofiber in rats with cavernous nerve injury", Mol Biol Rep, 48, pp.3549~3559 (2021)
- Sullivan CJ, "Microarray analysis reveals novel gene expression changes associated with erectile dysfunction in diabetic rats", Physiol Genomics, 23, pp.192~205 (2005)
- Ritchie ME, "limma powers differential expression analyses for RNA-sequencing and microarray studies", Nucleic Acids Res, 43, pp.e47~ (2015)
- Kuhn K, "A novel, high-performance random array platform for quantitative gene expression profiling", Genome Res, 14, pp.2347~2356 (2004)
- Tomomura M, "Structural and functional analysis of the apoptosisassociated tyrosine kinase(AATYK)family", Neuroscience, 148, pp.510~521 (2007)
- Jacovetti C, "Contribution of intronic miR-338-3p and Its hosting gene AATK to compensatory β-cell mass expansion", Mol Endocrinol, 29, pp.693~702 (2015)
- Jesmin S, "Diminished penile expression of vascular endothelial growth factor and its receptors at the insulin-resistant stage of a type II diabetic rat model : a possible cause for erectile dysfunction in diabetes", J Mol Endocrinol, 31, pp.401~418 (2003)
- Phay JE, "Cloning and expression analysis of a novel member of the facilitative glucose transporter family, SLC2A9(GLUT9)", Genomics, 66, pp.217~220 (2000)
- Vitart V, "SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout", Nat Genet, 40, pp.437~442 (2008)
- Döring A, "SLC2A9 influences uric acid concentrations with pronounced sex-specific effects", Nat Genet, 40, pp.430~436 (2008)
- Long H, "Hyperuricemia is an independent risk factor for erectile dysfunction", J Sex Med, 13, pp.1056~1062 (2016)
- Lane HA, "Antibody microinjection reveals an essential role for human polo-like kinase 1(Plk1)in the functional maturation of mitotic centrosomes", J Cell Biol, 135, pp.1701~1713 (1996)
- Shirakawa J, "Insulin signaling regulates the FoxM1", PLK1, Cell Metab, pp.2017, 25[DOI]
- Yang H, "Improvement of sexual function in POEMS syndrome after combination therapy of Lenalidomide and dexamethasone", Orphanet J Rare Dis, 11, pp.80~ (2016)
- Hanai T, "Application of bioinformatics for DNA microarray data to bioscience, bioengineering and medical fields", J Biosci Bioeng, 101, pp.377~384 (2006)
- Goyal SN, "Challenges and issues with streptozotocin-induced diabetes-A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics", Chem Biol Interact, 244, pp.49~63 (2016)
- Zhou F, "Effects of icariside II on improving erectile function in rats with streptozotocin-induced diabetes", J Androl, 33, pp.832~844 (2012)
- Schwanhäusser B, "Global quantification of mammalian gene expression control", Nature, 473, pp.337~342 (2011)